Overview
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions
Status:
Completed
Completed
Trial end date:
2006-07-01
2006-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to demonstrate the relative bioequivalence of Eplerenone 50 mg Tablets Under Fed Conditions.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
SandozTreatments:
Eplerenone
Spironolactone
Criteria
Inclusion Criteria:- No clinically significant abnormal finding on physical exam, medical history, or
clinical laboratory results on screening.
Exclusion Criteria:
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.